Press release
US Neurological Disorder Drugs Market Size, Industry Trends, Share and Forecast 2020-2026
Besides, frequent developments in healthcare and drug discovery are leading to the introduction of new drugs for the treatment of neurological diseases. Key authorities such as WHO, National Institutes of Health, and National Institute of Neurological Disorders and Stroke are taking productive steps that flares-up the research activities for the novel drug discovery. For instance, in August 2019, the National Center for Advancing Translational Sciences and National Institute of Neurological Disorders and Stroke invited researchers to conduct a study on rare neurological and neuromuscular disorders.
Request a Free Sample of our US Neurological Disorder Drugs Market: https://www.omrglobal.com/request-sample/us-neurological-disorder-drugs-market
Besides the presence of the key players such as Eli Lilly and Co., Merck & Co. Inc., and Pfizer Inc. are contributing to the growth of the US neurological disorder drugs market growth. Further, the well-established healthcare infrastructure and a significant rise in the population with the age group ranging between 18 and 64 are also driving the market growth. For instance, as per the US Census Bureau, the total population in the US was more than 325.7 million, of which 62% was constituted by 18-64 age group people.
A full Report of US Neurological Disorder Drugs Market is Available at: https://www.omrglobal.com/industry-reports/us-neurological-disorder-drugs-market
Market Coverage
• Market number available for – 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Disorder Type
• Country Covered- US
• Competitive Landscape- Eli Lilly and Co., Merck & Co. Inc., Abbvie Inc., Apotex Inc., AstraZeneca Plc, Pfizer Inc., Biogen Inc., and Amgen Inc.
Key questions addressed by the report
• What is the market growth rate?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID-19 forecast
o Most affected segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
US Neurological Disorder Drugs Market – Segmentation
By Disorder Type
• Alzheimer’s Disease
• Parkinson’s Disease
• Multiple Sclerosis
• Huntington Disease
• Others
Company Profiles
• AbbVie Inc.
• ACADIA Pharmaceuticals Inc.
• ApotexInc.
• Allergan Plc
• Amgen Inc.
• AstraZeneca Plc
• Biogen Inc.
• Eli Lilly and Co.
• Merck & Co. Inc.
• Pfizer Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-neurological-disorder-drugs-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Neurological Disorder Drugs Market Size, Industry Trends, Share and Forecast 2020-2026 here
News-ID: 2183391 • Views: …
More Releases from ORION MARKET RESEARCH
Trawler Yachts Market Size Future Scope, Demands and Projected Industry Growths …
The Trawler Yachts Market was valued at approximately USD 3.1 billion in 2023 and is projected to reach around USD 5.9 billion by 2032, growing at a compound annual growth rate (CAGR) of about 7.4% from 2024 to 2032.
Trawler Yachts Market Overview:
The Trawler Yachts market is witnessing significant growth, fueled by rising interest in long-range cruising and luxury boating experiences. Trawler yachts are known for their fuel efficiency, comfort, and…
Stuffed Animal & Plush Toys Market Size Future Scope, Demands and Projected Indu …
The Stuffed Animal & Plush Toys Market was valued at approximately USD 14.3 billion in 2023 and is anticipated to reach around USD 23.1 billion by 2032, growing at a compound annual growth rate (CAGR) of about 5.6% from 2024 to 2032.
Stuffed Animal & Plush Toys Market Overview:
The Stuffed Animal & Plush Toys market is experiencing steady growth, driven by the increasing demand for high-quality, safe, and innovative plush toys.…
Radial Forging Machine Market Analysis Current Landscape and Future Outlook
The Radial Forging Machine Market was valued at approximately USD 1.2 billion in 2023 and is expected to reach around USD 2.3 billion by 2032, growing at a compound annual growth rate (CAGR) of about 7.3% from 2024 to 2032.
Radial Forging Machine Market Overview:
The Radial Forging Machine market is experiencing steady growth, driven by increasing demand from industries such as aerospace, automotive, and heavy machinery. These machines are used to…
MSP Software Market Accelerating Growth with Future Market Size Strategies and T …
The MSP (Managed Service Provider) Software Market was valued at approximately USD 35.4 billion in 2023 and is projected to reach around USD 80.2 billion by 2032, growing at a compound annual growth rate (CAGR) of about 9.5% from 2024 to 2032.
MSP Software Market Overview:
The MSP Software market is experiencing robust growth due to the increasing demand for managed IT services across various industries. These software solutions are vital for…
More Releases for Disorder
Anti-Depressant Drugs Market to 2027 - Global Analysis and Forecasts By Depressi …
Anti-depressant drugs is a class of medications which is used to treat major depressive disorder, some anxiety disorders, some chronic pain conditions, and to help manage some addictions. Anti-depressant drugs also reduce symptoms of depressive disorders by correcting chemical imbalances of neurotransmitters in the brain. Chemical imbalances may be responsible for changes in mood and behavior.
Anti-depressant drugs market is anticipated to grow in the forecast period owing to driving factors…
Antidepressant Drugs Market Report 2018: Segmentation by Depressive Disorder (Ma …
Global Antidepressant Drugs market research report provides company profile for Alkermes Plc, Allergan Plc, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms…
Autism Spectrum Disorder (ASD) Treatment Market Report 2018: Segmentation by Aut …
Global Autism Spectrum Disorder (ASD) Treatment market research report provides company profile for Roche Pharmaceuticals, Autism Treatment Plus, Fraser, Retrophin, Inc., Autism Services Inc., Pfizer Inc., SynapDx, Behavior Analysis, Inc., Autism Therapeutics, Curemark LLC and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate,…
Speech Therapy Service Market Report 2018: Segmentation by Product (Speech Disor …
Global Speech Therapy Service market research report provides company profile for Benchmark Therapies, Talk Speech, Language Therapy, Speech Plus, Smart Speech Therapy, Therapy Solutions, Glenda Browne Speech Pathology and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018…
Somatostatin Receptor Market For Hormonal Disorder, Oncology, Metabolic Disorder
MarketResearchReports.Biz adds “Global Somatostatin Receptor Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Somatostatin Receptor and the growth estimates for the forecasted period.
This report studies the Somatostatin Receptor Type 2 market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global…
Thyroid Gland Disorder Treatment Market: Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of…
